| SIAT6_RAT |
Rattus norvegicus |
|
SIAT6_RAT is differentially expressed in 29 experiments [23 up/15 dn]: 10 organism parts: peritoneal fat [1 up/0 dn], kidney [0 up/1 dn], ...; 3 disease states: normal [1 up/0 dn], ischemia [0 up/1 dn], ...; 1 cell types, 8 compound treatments, 3 clinical treatments and 5 other conditions. |
| SIAT6_RAT, Siat6, St3gal3 |
|
ST3GAL3 (Homo sapiens)
St3gal3 (Mus musculus)
st3gal3 (Danio rerio)
(Compare orthologs)
|
|
|
| Glycosyl transferase, family 29, Sialyltransferase |
|
|
| N-acetyllactosaminide alpha-2,3-sialyltransferase activity, extracellular region, integral to Golgi membrane, protein amino acid glycosylation |
|
|
|
Q02734
|
|
|
|
ENSRNOG00000019843
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Peritoneal fat
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Tibialis anterior skeletal mus...
|
Organism part |
|
|
Extraocular skeletal muscle
|
Organism part |
|
|
P15
|
Developmental stage |
|
|
P30
|
Developmental stage |
|
|
Bisphenol A
|
Compound treatment |
|
|
Genestein
|
Compound treatment |
|
|
Dorsal striatum
|
Organism part |
|
|
None
|
Compound treatment |
|
|
LG100268
|
Compound treatment |
|
|
Interleukin 1 beta
|
Compound treatment |
|
|
Technical replicate 2
|
Replicate |
|
|
Biological replicate 3
|
Replicate |
|
|
Biological replicate 2
|
Replicate |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Sulphated cholecystokinin-8
|
Compound treatment |
|
|
Neurointermediate lobe
|
Organism part |
|
|
RI(BN-Lx/CubXSHR/Ola)
|
Strain or line |
|
|
Single exposure
|
Protocol type |
|
|
Repeated exposure
|
Protocol type |
|
|
Cerebellum
|
Organism part |
|
|
Hippocampus
|
Organism part |
|
|
Forskolin
|
Compound treatment |
|
|
Colon
|
Organism part |
|
|
Sertoli cell
|
Cell type |
|
|
Technical replicate 1
|
Replicate |
|
|
Fracture
|
Injury |
|
|
None
|
Injury |
|
|
Clofibrate
|
Compound treatment |
|
|
RI(SHR/OlaXBN-Lx/Cub)
|
Strain or line |
|
|
Normal
|
Disease state |
|
|
Ischemia
|
Disease state |
|
|
Ischemia followed by reperfusi...
|
Clinical treatment |
|
|
Sham surgery
|
Clinical treatment |
|
|
Trigger of ischemic preconditi...
|
Clinical treatment |
|
|
Moderate spinal cord injury
|
Disease state |
|
|
Biological replicate 1
|
Replicate |
|
|
|
|
|
Processing time: 0.095 secs.